Case Western Reserve University receives grant to investigate AML treatment for veterans

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) Med­ic­aid’s loss is … Sign up to

Japan­ese phar­ma­ceu­ti­cal com­pa­ny Ot­su­ka has en­list­ed Seat­tle-based RNA edit­ing biotech Shape Ther­a­peu­tics to de­vel­op new ade­no-as­so­ci­at­ed virus (AAV) vec­tors. The hope is to find new ways

Nu­va­tion Bio show­cased longer-term Phase 2 da­ta around the next-gen ROS1 in­hibitor it hopes will give Pfiz­er and Bris­tol My­ers Squibb a run for their